Alexander Gintsburg: Latest News

All news where Alexander Gintsburg is mentioned

12.06.2021 / 21:51

Russia tests nasal spray COVID-19 vaccine for children aged 8 to 12

Russia has tested a nasal spray form of its COVID- 19 vaccine that is suitable for children aged 8-12, and plans to launch the new product in September, the scientist who led the development of the Sputnik V vaccine said on Saturday.Alexander Gintsburg, who heads the Gamaleya Institute that developed Sputnik V, said the spray for children used the same vaccine “only instead of a needle, a nozzle is put on,” the TASS news agency reported. Heart inflammation cases higher in 16-24 age group after 2nd mRNA COVID-19 shot: CDC The children’s shot is expected to be ready for distribution by Sept.

Alexander Gintsburg Russia covid-19 testing vaccine

Russia resumes covid-19 vaccine trial after pause

Russia has resumed the vaccination of new volunteers in its trial for its flagship COVID-19 Sputnik V vaccine after a short pause, staff at six of 29 trial clinics said, as Moscow moves to accelerate plans to inoculate the population.At the end of October, eight clinics told Reuters that the trial had been temporarily paused for new volunteers, with some clinics citing high demand and a shortage of doses.Alexander Gintsburg, director of the Gamaleya Institute, which developed and manufactures the vaccine, said at the time that the uptake of new volunteers had only slowed because of a decision to focus on giving those already vaccinated a second dose."Vaccination has resumed.

Alexander Gintsburg Russia city Moscow covid-19 vaccine Volunteers

Scientist behind Russia coronavirus vaccine defends ‘wartime’ rollout during trial

Russia plans to share preliminary results of its COVID-19 vaccine trial based on the first six weeks of monitoring participants, raising the tempo in an already frenzied global race to end the pandemic.Alexander Gintsburg, head of the Gamaleya Institute that produced the Sputnik V vaccine, told Reuters that the pace of its development was necessary under the “wartime” conditions of a pandemic but no corners were being cut.

Alexander Gintsburg Russia covid-19 Coronavirus

'People dying like during a war': Russian scientist defends covid vaccine launch

MOSCOW : Russia plans to share preliminary results of its COVID-19 vaccine trial based on the first six weeks of monitoring participants, raising the tempo in an already frenzied global race to end the pandemic.Alexander Gintsburg, head of the Gamaleya Institute that produced the Sputnik V vaccine, told Reuters that the pace of its development was necessary under the "wartime" conditions of a pandemic but no corners were being cut.Russia has pushed ahead with its potential COVID-19 vaccine at top speed with mass public vaccinations alongside the main human trial, raising concerns among some observers that it was prioritising national prestige over solid science and safety."People are dying just like during a war," said Gintsburg, holding a

Alexander Gintsburg Russia city Moscow covid-19 vaccine Volunteers infection

COVID-19 vaccine Sputnik V: Russia wants to partner India

vaccine is a very important issue. Currently, we are looking for a partnership with India.

Alexander Gintsburg India Italy Russia Brazil Saudi Arabia Uae virus covid-19 vaccine

Russia says covid vaccine will protect for at least two years: Report

A top Russian official said that the vaccine developed by the country will offer protection from covid for at least two years. On Tuesday, Russia became the first worldwide to register the vaccine against the coronavirus."Effective period of the vaccine, its protective properties will last not during a short term, half a year - one year but for at least two years," said Alexander Gintsburg, the director of Gamaleya research center, according to Russian news agency TASS.

Alexander Gintsburg Russia experts vaccine Coronavirus

Russia hints at how the world's first covid vaccine will work

covid vaccine will work. The vaccine has been developed jointly by the Gamaleya Research Institute and the Russian Defence Ministry.Alexander Gintsburg, director of the Gamaleya National Research Centre, said that vaccine used inanimate particles created on the basis of adenovirus, according to Sputnik News.He said there are no concerns that the vaccine could potentially cause harm to a person's health.“The particles and objects that can reproduce their own kind are the ones that are considered alive.

Alexander Gintsburg Russia testing vaccine Coronavirus

Russia targets to launch first coronavirus vaccine next month: Report

world's first Covid-19 vaccine from Russia pouring in since the last few days, Russian scientists said they are eyeing to launch the vaccine by mid-August, according to a report.According to Director of the Gamaleya Scientific Research Institute, Alexander Gintsburg, there are hopes that "a small amount" of the vaccine would be available to people in the middle of August, and private companies would start producing vaccines in the beginning or the middle of September, as reported by Sputnik News.The head of the research institute added that the vaccine would not be available in pharmacies in the near future.However, the report also citied Mikhail Schelkanov, the head of the microbe ecology lab at the School of Biomedicine of Russia's Far

Alexander Gintsburg Russia vaccine Coronavirus

United States	Cases: 46 252 513 Deaths: 750 423 Recovered: 0
India	Cases: 34 321 025 Deaths: 459 652 Recovered: 0
Brazil	Cases: 21 835 785 Deaths: 608 235 Recovered: 0
United Kingdom	Cases: 9 215 683 Deaths: 141 607 Recovered: 0
Russia	Cases: 8 494 589 Deaths: 237 619 Recovered: 0